Kern P A, Robbins R J, Bichet D, Berl T, Verbalis J G
J Clin Endocrinol Metab. 1986 Jan;62(1):148-52. doi: 10.1210/jcem-62-1-148.
The syndrome of inappropriate antidiuresis (SIAD) is usually associated with inappropriately elevated plasma arginine vasopressin (AVP) concentrations. We describe herein a patient with a macroprolactinoma who had symptomatic hyponatremia due to SIAD. Although the patient had excessive thirst, severe plasma hypoosmolality, and hyperosmolar urine, no immunoassayable AVP could be detected. During long term treatment with bromocriptine, there was gradual shrinkage of the prolactinoma coincident with improvement in the ability to excrete a water load and normalization of the thirst threshold. At this point, plasma immunoactive AVP was measurable during a hypertonic saline infusion for the first time. By high pressure liquid chromatographic analysis, this immunoactive substance coeluted with AVP. These studies suggest that the SIAD in this patient was due to the production of an antidiuretic substance distinct from AVP in association with his prolactinoma.
抗利尿激素分泌失调综合征(SIAD)通常与血浆精氨酸血管加压素(AVP)浓度不适当升高有关。我们在此描述一名患有大泌乳素瘤的患者,其因SIAD出现有症状的低钠血症。尽管该患者有极度口渴、严重的血浆低渗和高渗尿,但未检测到可免疫测定的AVP。在使用溴隐亭长期治疗期间,泌乳素瘤逐渐缩小,同时水负荷排泄能力改善,口渴阈值恢复正常。此时,在静脉输注高渗盐水期间首次可检测到血浆免疫活性AVP。通过高压液相色谱分析,这种免疫活性物质与AVP共洗脱。这些研究表明,该患者的SIAD是由于与他的泌乳素瘤相关的一种不同于AVP的抗利尿物质产生所致。